Myositis interstitial lung disease and autoantibodies

被引：3

作者：

Chaudhry, Shire ^{[1
]}

Christopher-Stine, Lisa ^{[2
]}

机构：

[1] Luminis Hlth Anne Arundel Med Ctr, Dept Med, Annapolis, MD USA

[2] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD 21205 USA

来源：

FRONTIERS IN MEDICINE | 2023年 / 10卷

关键词：

myositis; interstitial lung disease; myositis specific autoantibodies; pulmonary fibrosis; narrative review; IDIOPATHIC INFLAMMATORY MYOPATHIES; CLINICAL SPECTRUM; JAPANESE PATIENTS; DERMATOMYOSITIS; POLYMYOSITIS; ANTIBODIES; PREVALENCE; ADULT; ASSOCIATION; PHENOTYPE;

D O I：

10.3389/fmed.2023.1117071

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this review is to examine and evaluate published literature associated with idiopathic inflammatory myopathies (IIM) and interstitial lung disease (ILD) based on myositis specific autoantibodies (MSA) and the potential clinical significance of each autoantibody subtype for the practicing clinician. The review is a comprehensive search of literature published in PubMed from the year 2005 and onward coinciding with the surge in the discovery of new MSAs. Additionally, we comment on recommended multidisciplinary longitudinal care practices for patients with IIM-ILD with regard to imaging and other testing. Treatment is not covered in this review.

引用

页数：11

共 50 条

[21] Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies [J].

Christopher A. Mecoli ;

Lisa Christopher-Stine .

Current Rheumatology Reports, 2018, 20

[22] Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease [J].

Moll, Sofia A. ;

Platenburg, Mark G. J. P. ;

Platteel, Anouk C. M. ;

Vorselaars, Adriane D. M. ;

Bonas, Montse Janssen ;

Roodenburg-Benschop, Claudia ;

Meek, Bob ;

van Moorsel, Coline H. M. ;

Grutters, Jan C. .

JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) :1-14

[23] Presenting clinical and imaging features of patients with clinically amyopathic interstitial lung disease associated with myositis-specific autoantibodies [J].

Tzilas, Vasilios ;

Tzouvelekis, Argyrios ;

Sotiropoulou, Vasilina ;

Panopoulos, Stylianos ;

Bouros, Evangelos ;

Avdoula, Eleni ;

Ryu, Jay H. ;

Bouros, Demosthenes .

FRONTIERS IN MEDICINE, 2024, 11

[24] Interstitial lung disease and myositis [J].

Gono, Takahisa ;

Kuwana, Masataka .

CURRENT OPINION IN RHEUMATOLOGY, 2024, 36 (06) :466-472

[25] Interstitial Lung Disease in Myositis: Clinical Subsets, Biomarkers, and Treatment [J].

Tsuneyo Mimori ;

Ran Nakashima ;

Yuji Hosono .

Current Rheumatology Reports, 2012, 14 :264-274

[26] “Management of myositis associated interstitial lung disease” [J].

Lorraine Thong ;

Liam J. Chawke ;

Grainne Murphy ;

Michael T. Henry .

Rheumatology International, 2023, 43 :1209-1220

[27] Clinical and Pathological Findings of Interstitial Lung Disease Patients with Anti-Aminoacyl-tRNA Synthetase Autoantibodies [J].

Koreeda, Yoshimizu ;

Higashimoto, Ikkou ;

Yamamoto, Masuki ;

Takahashi, Mikiko ;

Kaji, Kenzo ;

Fujimoto, Manabu ;

Kuwana, Masataka ;

Fukuda, Yuh .

INTERNAL MEDICINE, 2010, 49 (05) :361-369

[28] Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease [J].

Burbelo, Peter D. ;

Huapaya, Julio A. ;

Khavandgar, Zohreh ;

Beach, Margaret ;

Pinal-Fernandez, Iago ;

Mammen, Andrew L. ;

Chiorini, John A. ;

Farhadi, Payam Noroozi ;

Miller, Frederick W. ;

Schiffenbauer, Adam ;

Sarkar, Kakali ;

Warner, Blake M. ;

Rider, Lisa G. .

FRONTIERS IN IMMUNOLOGY, 2024, 15

[29] Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression [J].

Gunawardena, Harsha ;

Betteridge, Zoe E. ;

McHugh, Neil J. .

RHEUMATOLOGY, 2009, 48 (06) :607-612

[30] Idiopathic Inflammatory Myositis (IIM) Related Interstitial Lung Disease (ILD): Treatment Options [J].

Alrehaili, Ghadah ;

Farah, Wigdan ;

Tzilas, Vasilios ;

Baqir, Misbah .

CURRENT PULMONOLOGY REPORTS, 2025, 14 (01)

← 1 2 3 4 5 →